REXALL DRUGS INC

Contact details

Work email

Not on file

Home address

Not matched

Cell phone

Not matched

Contact details are revealed to signed-in customers one provider at a time, counted against a daily allowance and logged. See plans.

Leadership on file

1 named leadership contact on file, by role:

Owner

1

Executives, officers and owners as public filings name them, with the title each filing gives them. Leadership across US healthcare, by role.

What they bill and prescribe

The procedures this provider billed Medicare for, code by code, and the drugs they prescribed under Part D — from published Medicare data for 2024, for signed-in customers. Search can be filtered on either by name, so “knee replacement” and “Eliquis” are queries rather than codes.

Published Medicare fee-for-service data for 2024, covering about one in four clinicians nationally, and more in the specialties that bill it most — not all-payor claims, and low-volume providers are removed before publication. A provider with nothing published has no published Medicare volume, which covers no volume, volume below the publication threshold and not billing Medicare at all — the published data does not separate them. Provider-level aggregates only; nothing patient-level exists here. What it covers.

Also in the record

Group affiliations and employers, facility ownership, programme standing and licence detail appear here for signed-in customers.